Not yet recruitingPhase 2NCT07167966

Alzheimer's Tau Platform: Regimen A - AADvac1

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Paul S. Aisen
Principal Investigator
Adam Boxer, MD, PhD
University of California, San Francisco (UCSF), Memory and Aging Center
Intervention
AADvac1(drug)
Enrollment
450 enrolled
Eligibility
50-80 years · All sexes
Timeline
2026 – 2028

Collaborators

Axon Neuroscience SE · University of California, San Francisco · Massachusetts General Hospital · Alzheimer's Therapeutic Research Institute · Alzheimer's Clinical Trials Consortium · National Institute on Aging (NIA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07167966 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials